Top news of the week: 29.09.2020.
#COVID19 #lifesciences #COVID #treatment #biotechnology #vaccine #coronavirus #biospace #pharmaceuticals #pandemic
Companies And Industries
South Korean exosome biotech Ilias Biologics nabs $20M B round https://t.co/wd0Ld3u5eb https://t.co/sV9jlsF2qv
OpenSouth Korean exosome biotech Ilias Biologics nabs $20M B round
Preclinical inflammatory disease biotech Ilias Biologics has grabbed a $20.6 million funding round as it eyes a 2021 human test of its leading candidate ILB-202.
RT @AmgenFoundation: Thirty years ago, Amgen scientists came together with local high school teachers to transform how #science is introduced, experienced, and accessed all over the world. Happy anniversary, @ABEProgOffice 🎂🎈🎉 #ScienceMadePossible https://t.co/NmK6PAzCnT https://t.co/DYcCERGNHI
OpenAmgen Foundation Commits $16.4M to the Amgen Biotech Experience
The announcement comes on the 30th Anniversary of the ABE program, which has successfully delivered hands on biotechnology labs to nearly 850,000 students.
Biopharma Update on the Novel Coronavirus: September 25
#biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/lkll4ZIgMf
OpenBiopharma Update on the Novel Coronavirus: September 25
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
Biopharma Update on the Novel Coronavirus: September 28
#biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/5rN7SnG0V4
OpenBiopharma Update on the Novel Coronavirus: September 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 28, 2020.
Flexible Platform Solutions Overcome Vaccine Production Challenges
A Guest Article by Pall Biotech The team from Pall Biotech explores the challenges of vaccine development and how they can be overcome by applying a quality by design (QbD) …
Imperative to most clinical studies is #immune cell monitoring. But it requires viable cells. The problem: sample logistics can be challenging! 🧗♀️#biotech https://t.co/4mKz4joY3b @Precision4Med
OpenHow a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring
Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require viable cells, a demand often torpedoed by sample logistics. What do cancer, ...
“Debugging a problem in the therapeutics space is very costly and disruptive, because the cause is often a mystery,” explains .@sridiyengar, PhD, CEO and founder of .@Elemental_io. Personalized Medicine Manufacturing Needs “Debugging Tools”. Learn more: https://t.co/nwDej3qeEv https://t.co/22jQObB7Ea
OpenPersonalized Medicine Manufacturing Needs “Debugging Tools”
Machine learning/AI and automation can help researchers and manufacturers identify where a problem lies.
Looking forward to @Ashley_VanZ sharing about #covid19 & #genomics with K12 educators in an upcoming speaker series (Oct 21). @BiocomInstitute will be sharing the endless ways to bring DNA into classrooms. Educators register here https://t.co/3HX6BqJ1Sg #stem #ngss https://t.co/yNsNBkfcsT
OpenThe Life Science Industry Speaker Series for Educators Ashley Van Zeeland, Illumina VP of Product Integration & Customer Collaboration
The Life Science Industry Speaker Series for Educators Ashley Van Zeeland, Illumina VP of Product Integration & Customer Collaboration